Literature DB >> 18656823

When and how to grade Barrett's columnar metaplasia: the Prague system.

Oksana Anand1, Sachin Wani, Prateek Sharma.   

Abstract

Barrett's oesophagus (BO), a well-known precursor for oesophageal adenocarcinoma has been generating a great deal of controversy. The initial step in diagnosing BO requires an accurate endoscopic recognition of the columnar lined oesophagus. A reliable diagnosis of BO depends on its effective endoscopic recognition based on the key anatomic landmarks, followed by histological sampling of the columnar-lined epithelium. Precise localisation of the gastrooesophageal junction is pivotal in the endoscopic diagnosis of BO. Multiple ad-hoc grading systems and terminologies of BO have been proposed based on the Z-line appearance, presence or absence of intestinal metaplasia, and the length of Barrett's segment. However, a universally accepted standardised endoscopic grading system of BO is lacking. The Prague C&M criteria, developed by a subgroup of the International Working Group for the Classification of Oesophagitis, are the first explicit, consensus-driven, clinically relevant criteria for the endoscopic recognition and grading of BO that may be useful in both clinical practice and research trials.

Entities:  

Mesh:

Year:  2008        PMID: 18656823     DOI: 10.1016/j.bpg.2008.02.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  8 in total

1.  No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus.

Authors:  Aaron P Thrift; Jennifer R Kramer; Peter A Richardson; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2013-10-11       Impact factor: 3.199

2.  Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea.

Authors:  Jung Wan Choe; Young Choon Kim; Moon Kyung Joo; Hyo Jung Kim; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Jae Seon Kim; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastrointest Endosc       Date:  2016-04-25

Review 3.  Endoscopic Diagnosis and Management of Barrett's Esophagus with Low-Grade Dysplasia.

Authors:  Francesco Maione; Alessia Chini; Rosa Maione; Michele Manigrasso; Alessandra Marello; Gianluca Cassese; Nicola Gennarelli; Marco Milone; Giovanni Domenico De Palma
Journal:  Diagnostics (Basel)       Date:  2022-05-23

4.  Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study.

Authors:  Hashem B El-Serag; Ali Hashmi; Jose Garcia; Peter Richardson; Abeer Alsarraj; Stephanie Fitzgerald; Marcelo Vela; Yasser Shaib; Neena S Abraham; Maria Velez; Rhonda Cole; Margot B Rodriguez; Bhupinderjit Anand; David Y Graham; Jennifer R Kramer
Journal:  Gut       Date:  2013-02-13       Impact factor: 23.059

Review 5.  Management strategies of Barrett's esophagus.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

6.  Radiofrequency ablation in the management of Barrett's esophagus - preliminary own experience.

Authors:  Wojciech P Dąbrowski; Andrzej B Szczepanik; Andrzej Misiak; Konrad Pielaciński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-01-16       Impact factor: 1.195

7.  Distal Esophageal Impedance Measured by High-resolution Esophageal Manometry With Impedance Suggests the Presence of Barrett's Esophagus.

Authors:  Rahul Kataria; Benjamin Rosenfeld; Zubair Malik; Martha Harrison; Michael S Smith; Ron Schey; Henry P Parkman
Journal:  J Neurogastroenterol Motil       Date:  2020-07-30       Impact factor: 4.924

8.  LAPAROSCOPIC REDO FUNDOPLICATION ALONE, REDO NISSEN FUNDOPLICATION, OR TOUPET FUNDOPLICATION COMBINED WITH ROUX-EN-Y DISTAL GASTRECTOMY FOR TREATMENT OF FAILED NISSEN FUNDOPLICATION.

Authors:  Italo Braghetto; Owen Korn; Manuel Figueroa-Giralt; Catalina Valenzuela; Ana Maria Burgos; Carlos Mandiola; Camila Sotomayor; Eduardo Villa
Journal:  Arq Bras Cir Dig       Date:  2022-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.